SEARCH

SEARCH BY CITATION

References

  • 1
    Codex-Alimentarius-Commission. Codex Standard. Joint FAO/WHO Food Standards Programme, Rome 118, 1981.
  • 2
    Codex-Alimentarius-Commission. Report of the Working Groups on Prolamin Analysis an Toxicity (WGPAT). Joint FAO/WHO Food Standards Programme; CX/NFSDU03/4 Rome, 2003.
  • 3
    Stern M, Ciclitira PJ, van Eckert R, et al. Analysis and clinical effects of gluten in coeliac disease. Eur J Gastroenterol Hepatol 2001; 13: 7417.
  • 4
    Ciclitira PJ, Evans DJ, Fagg NL, Lennox ES, Dowling RH. Clinical testing of gliadin fractions in coeliac patients. Clin Sci 1984; 66: 35764.
  • 5
    Ferguson A, Blackwell JN, Barnetson RS. Effects of additional dietary gluten on the small-intestinal mucosa of volunteers and of patients with dermatitis herpetiformis. Scand J Gastroenterol 1987; 22: 5439.
  • 6
    Catassi C, Rossini M, Rätsch I-M, et al. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 1993; 34: 15159.
  • 7
    Montgomery AM, Goka AK, Kumar PJ, Farthing MJ, Clark ML. Low gluten diet in the treatment of adult coeliac disease: effect on jejunal morphology and serum anti-gluten antibodies. Gut 1988; 29: 15648.
  • 8
    Grefte JM, Bouman JG, Grond J, Jansen W, Kleibeuker JH. Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol 1988; 41: 88691.
  • 9
    Kaukinen K, Collin P, Holm K, et al. Wheat starch-containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study. Scand J Gastroenterol 1999; 34: 1649.
  • 10
    Högberg L, Stenhammar L, Wagermark J. Very late mucosal relapse in a girl with coeliac disease. Acta Paediatr 1993; 82: 8879.
  • 11
    Ejderhamn J, Veress B, Strandvik B. The long-term effect of continual ingestion of wheat starch-containing gluten-free products in coeliac patients. In: Kumar, PJ, ed. Coeliac Disease: One Hundred Years. Leeds: Leeds University Press, 1988: 2947.
  • 12
    Collin P, Reunala T, Pukkala E, Laippala P, Keyriläinen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35: 12158.
  • 13
    Peräaho M, Kaukinen K, Paasikivi K, et al. Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease. Prospective and randomized study. Aliment Pharmacol ther 2003; 17: 58794.
  • 14
    Denery-Papini S, Nicolas Y, Popineau Y. Efficiency and limitations of immuno-chemical assays for the testing of gluten-free foods. J Cereal Sci 1999; 30: 12131.
  • 15
    Valdes I, Carcia E, Llorente M, Mendez E. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol. Eur J Gastoenterol Hepatol 2003; 15: 46574.
  • 16
    Immer U, Vela C, Mendez EFJ. PWG collaborative trial on gluten in gluten-free food through ‘Coctail Elisa’. In: Stern, M, ed. Proceedings of the 17th Meeting Working Group on Prolamin Analysis and Toxicity. Zwickau: Verla Wissenschaftliche Scripten, 2002: 2333.
  • 17
    Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 7768.
  • 18
    Collin P, Mäki M, Kaukinen K. Complete small intestinal mucosal recovery is obtainable in the treatment of celiac disease. Gastrointest Endosc 2003; 59: 1589.
  • 19
    Lee SK, Lo W, Memeo L, Rotterdam H, Green PHR. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc 2003; 57: 18791.
  • 20
    Lohiniemi S, Mäki M, Kaukinen K, Laippala P, Collin P. Gastrointestinal symptoms rating scale in coeliac disease patients on wheat starch-based gluten-free diet. Scand J Gastroenterol 2000; 35: 9479.
  • 21
    Collin P, Pukkala E, Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 1996; 38: 52830.
  • 22
    Cooper BT, Read AE. Coeliac disease and lymphoma. Q J Med 1987; 63: 26974.
  • 23
    Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI. Risk of malignancy in patients with celiac disease. Am J Med 2003; 115: 1915.
  • 24
    Ciclitira PJ, Ellis HJ, Fagg NL. Evaluation of a gluten free product containing wheat gliadin in patients with coeliac disease. BMJ 1984; 289: 83.
  • 25
    Ciclitira PJ, Cerio R, Ellis HJ, Maxton D, Nelufer JM, Macartney JM. Evaluation of a gliadin-containing gluten-free product in coeliac patients. Hum Nutr Clin Nutr 1985; 39C: 3038.
  • 26
    Sturgess R, Day P, Ellis HJ, et al. Wheat peptide challenge in coeliac disease. Lancet 1994; 343: 75861.
  • 27
    Srinivasan U, Leonard N, Jones E, et al. Absence of oats toxicity in adult coeliac disease. BMJ 1996; 313: 13001.
  • 28
    Laurin P, Wolving M, Fälth-Magnusson K. Even small amounts of gluten cause relapse in children with celiac disease. J Pediatr Gastroenterol Nutr 2002; 34: 2630.
  • 29
    Chartrand LJ, Russo PA, Duhaime AG, Seidman EG. Wheat starch intolerance in patients with celiac disease. J Am Diet Assoc 1997; 97: 6128.
  • 30
    Selby WS, Painter D, Collins A, Faulkner-Hogg KB, Loblay RH. Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten. Scand J Gastroenterol 1999; 34: 90914.